TrialBlood advances2022

Scheduled administration of virus-specific T cells for viral prophylaxis after pediatric allogeneic stem cell transplant.

Jeremy D Rubinstein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.